<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd"><article xml:lang="KO" article-type="case-report">

<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Korean J Gynecol Oncol Colposc</journal-id>
<journal-id journal-id-type="publisher-id">KJGOC</journal-id>
<journal-title-group>
<journal-title>Korean Journal of Gynecologic Oncology and Colposcopy</journal-title>
</journal-title-group>
<issn pub-type="ppub">0300-4015</issn><publisher>
<publisher-name>Korean Society of Gynecologic Oncology and Colposcopy</publisher-name>
</publisher>
</journal-meta>

<article-meta>
<article-id pub-id-type="doi">10.3802/kjgoc.2004.15.2.149</article-id>
<article-categories>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Case of Sertoli-Leydig Cell Tumor of the Ovary</article-title>
</title-group>

<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Kwe Wang</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Sang Woo</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shin</surname>
<given-names>Kyu Sik</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Myeon Soo</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ku</surname>
<given-names>Seon Yeong</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kwak</surname>
<given-names>Tae Ro</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>
</contrib-group>

<aff id="A1">Department of Obstetrics and Gynecology, Wallace Memorial Bapist Hospital, Busan, <country>Korea</country>.</aff>

<pub-date pub-type="ppub">
<month>06</month>
<year>2004</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>03</month>
<year>2019</year>
</pub-date>
<volume>15</volume>
<issue>2</issue>
<fpage>149</fpage>
<lpage>153</lpage>

<permissions>
<copyright-statement>Copyright &#x00A9; Korean Society of Gynecologic Oncology and Colposcopy</copyright-statement>
<copyright-year>2004</copyright-year>
</permissions>

<abstract>
<p>The Sertoli-Leydig cell tumor is a rare sex cord-stromal tumor of the ovary, accounting for less than 0.5% of all primary ovarian neoplasm. They occur predominantly in the second and third decades, rarely before puberty or after the menopause. The most common symptom is menstrual disorder including vaginal bleeding and occasionally masculinization is accompanied with this symptom. This symptom is the results of excessive testosterone production of Leydig cell, but approximately 50% of patients with Sertoli-Leydig cell tumor have no endocrine manifestations. The majority of these tumors are benign and almost all are localized unilaterally. Prognosis proves generally favorable with 5-year survival rate of 70~90%. Recurrence is rare. We have experienced a case of intermediately differentiated Sertoli-Leydig cell tumor accompanied with multiple uterine leiomyomas in a 30 years old woman who had oligomenorrhea, hirsutism and infertility. We report this case with a brief review of literature.</p>
</abstract>

<kwd-group>
<kwd>Sertoli-Leydig cell tumor</kwd>
<kwd>Oligomenorrhea</kwd>
<kwd>Hirsutism</kwd>
<kwd>Infertility</kwd>
</kwd-group>

</article-meta>
</front>
</article>